Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
Analysis
Comment
Deals
Events
News
People

Deals

Lemonade demonstrates $319m flotation
SoftBank, XL Catlin, Allianz and Alphabet-backed casualty and property isnurance provider Lemonade priced the initial public offering above its range.
Annexon adds $100m
The round pushed the overall funding for the Novartis-backed autoimmune and neurodegenerative disorder drug developer past $250m.
Google points North to acquisition
Google paid a reported $180m for Amazon and Intel-backed North Wearables, the augmented reality glasses developer having sought a buyer since spring.
Bolt latches onto series C financing
Novo, Pfizer and Nan Fung helped provide $93.5m for the cancer treatment developer as it advances its lead product candidate towards the clinic.
Away packs up bridge financing
Comcast Ventures-backed smart luggage brand Away has reportedly secured $30m to $40m in bridge financing as it faces a downturn in business due to the coronavirus.
Mynd houses series C funding
Wells Fargo led a $41.5m round for the tech-equipped property manager that included existing backers Canaan Partners, Lightspeed Venture Partners and Jackson Square Ventures.
SmartMore arcs to pre-series A round
The computer vision technology startup has secured tens of millions of dollars in a round featuring Lenovo Capital, just over six months after it was founded.
Shift gears up for reverse merger
The Lithia Motors, BMW and Alliance Ventures-backed automotive e-commerce marketplace is set to go public through a reverse merger with Insurance Acquisition.

News Continued

Mirror reflects on $500m acquisition
At-home fitness company Mirror is set to be acquired by Lululemon for $500m, after the corporate contributed to its series B round in November.
Coty cuts off $200m for KKW investment
The beauty and cosmetics group is acquiring a 20% stake in Kim Kardashian West's beauty brand at a $1bn valuation in connection with a partnership agreement.
CapitalBio Technology cashes $113m
Sinopec Capital and Meinian Onehealth both invested in the biotech research product maker as it prepares for an initial public offering.
Goldfinch Bio holds on to $100m
Existing backer Gilead Sciences returned for a series B round that boosted the kidney disease therapy developer's total funding to $160m.
Discord discovers another $100m
Index Ventures participated in a round that valued the WarnerMedia and Tencent-backed communication platform developer at $3.5bn.
SolarisBank heats up with series C financing
Samsung Catalyst Fund, BBVA, SBI Group and ABN Amro Ventures chipped in as the banking platform developer raised $67.3m at a $360m valuation.

Editor's Picks

Lemonade demonstrates $319m flotation
SoftBank, XL Catlin, Allianz and Alphabet-backed casualty and property isnurance provider Lemonade priced the initial public offering above its range.
Forma Therapeutics finishes IPO at $319m
Forma Therapeutics, whose investors include Eli Lilly and Novartis, has closed its IPO after seeing its shares double in price.
Forma forces its way to $278m IPO
The Novartis and Eli Lilly-backed cancer and haematologic disease drug developer will go public today having expanded the size of its offering.
Avidity achieves $259m initial public offering
Muscle disease drug developer Avidity, which counts Eli Lilly, EMS, Takeda and ST Pharm as investors, went public in a significantly upized IPO.
test reg

Login